Ark Genomic Revolution UCITS ETF (SWX:ARKG)

Assets	89.66M
Expense Ratio	0.79%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+97.60%

Volume	15,783
Open	7.90
Previous Close	7.92
Day's Range	7.89 - 8.13
52-Week Low	3.76
52-Week High	8.13
Beta	n/a
Holdings	32
Inception Date	Apr 12, 2024

About ARKG

AAKG.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to generate long term capital growth (5 years or more)

• Asset Class: Equity
• Category: Theme
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ARKG
• Provider: ARK

Performance

ARKG had a total return of 97.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 40.86%.

Top 10 Holdings

58.93% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	9.72%
Tempus AI, Inc.	TEM	9.22%
10x Genomics, Inc.	TXG	7.41%
CRISPR Therapeutics AG	CRSP	5.53%
Absci Corporation	ABSI	4.89%
Natera, Inc.	NTRA	4.61%
CareDx, Inc.	CDNA	4.61%
Illumina, Inc.	ILMN	4.50%
Personalis, Inc.	PSNL	4.46%
Eli Lilly and Company	LLY	3.98%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error